(Q37954519)

25 August 2017

Hypofractionated radiation therapy in the treatment of early-stage breast cancer (English)

1 reference

25 August 2017

0 references

Gary M Freedman

1

1 reference

25 August 2017

1 February 2012

1 reference

25 August 2017

Current Oncology Reports

1 reference

25 August 2017

14

1 reference

25 August 2017

1

1 reference

25 August 2017

12-19

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-011-0207-7

25 August 2017

0 references

cites work

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Long-term results of hypofractionated radiation therapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Pattern of local recurrence after conservative surgery and whole-breast irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Accelerated partial breast irradiation as a part of breast conservation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/ II breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: results of a matched-pair analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

A Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

Radiotherapy for invasive breast cancer in North America and Europe: Results of a survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-011-0207-7

A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer.

21 January 2018

1 reference

12 December 2020

Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study

1 reference

12 December 2020

Accelerated partial breast irradiation

1 reference

12 December 2020

Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working gr

1 reference

12 December 2020

Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials

1 reference

12 December 2020

Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial

1 reference

12 December 2020

Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer

1 reference

12 December 2020

Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma--5-year results of a randomized trial

1 reference

12 December 2020

Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13

1 reference

12 December 2020

Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy

1 reference

12 December 2020

Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France

1 reference

12 December 2020

Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial

1 reference

12 December 2020

10.1007/S11912-011-0207-7

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

22071682